Showing results (581-590 of 779) with videos related to
Sort By:
Pageof 78
The Oncologist|February 25, 2012
Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003Elizabeth Fox, Shreyaskumar Patel, J Kyle Wathen, et al.Cancer Treatment Reports|July 1, 1978
Glycerol: a successful alternative to dexamethasone for patients receiving brain irradiation for metastatic diseaseA Y Bedikian, M Valdivieso, L K Heilbrun, et al.The British Journal of Surgery|October 1, 1987
Total pancreatectomy for chronic pancreatitisM J Cooper, R C Williamson, I S Benjamin, et al.Cancer Chemotherapy and Pharmacology|January 1, 1984
Human tissue distribution of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (NSC 141549, AMSA)D J Stewart, G Zhengang, K Lu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2003
Importance of predosing of recombinant human thrombopoietin to reduce chemotherapy-induced early thrombocytopeniaSaroj Vadhan-Raj, Shreyaskumar Patel, Carlos Bueso-Ramos, et al.Cancer Research|February 1, 1983
Clinical pharmacology of intraarterial cis-diamminedichloroplatinum(II)D J Stewart, R S Benjamin, S Zimmerman, et al.American Journal of Clinical Oncology|June 1, 1985
A phase II trial of PCNU in patients with malignant melanoma and central nervous system metastasesL D Feldman, L G Feun, R S Benjamin, et al.Oncotarget|June 27, 2013
Germline PTPRD mutations in Ewing sarcoma: biologic and clinical implicationsYunyun Jiang, Filip Janku, Vivek Subbiah, et al.Brain Tumor Pathology|November 13, 2014
C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcomaDavid Cachia, Khalida Wani, Marta Penas-Prado, et al.Journal of the American Chemical Society|May 4, 2018
Programmable Topology in New Families of Heterobimetallic Metal-Organic FrameworksPatrick F Muldoon, Chong Liu, Carson C Miller, et al.Pageof 78